Iovance Biotherapeutics

Biotechnology

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient.

IOVA

Visualizar Fundamentos

Iovance Biotherapeutics

6,2

P/B

2500

P/S

—

P/EBITDA

—

Forward P/E

2,1

BVPS

—

EPS